Viewing Study NCT06602986



Ignite Creation Date: 2024-10-26 @ 3:40 PM
Last Modification Date: 2024-10-26 @ 3:40 PM
Study NCT ID: NCT06602986
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-09-14

Brief Title: Measuring the Density of Iodine in Lipiodol Depositions Detecting an Invisible Residual Tumor After Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma
Sponsor: None
Organization: None

Study Overview

Official Title: Measuring the Density of Iodine in Lipiodol Depositions Detecting an Invisible Residual Tumor After Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: ABSTRACT Objective To detect presence of a residual tumor in patients of hepatocellular carcinoma HCC treated with Lipiodol based conventional trans arterial chemoembolization cTACE using density measurements on follow-up computed tomography CT scans Study Design Prospective observational interventional study Place and Duration of Study Interventional Radiology department of Armed Forces Institute of Radiology and Imaging AFIRI from April 2023-March 2024 Methodology 96 patients undergoing conventional TACE were included in the study and followed up for residual tumor or tumor free status assessment using density measurement for iodine depositions using CT scan analysis and compared with gold standard digital subtraction angiography DSA Primary variables measured were comparison of enhancement scores between those with a residual tumor versus tumor free as well as the volume of iodine depositions in the arterial and venous phase between both groups Sensitivity and specificity of the CT scan in assessing tumor diagnosis was compared with the gold standard digital subtraction angiography
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None